SYSTEMIC MARKERS FOR ASTHMA AND ANALOGOUS DISEASES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

13069078

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are diagnostic and prognostic methods, diagnostic and prognositic markers, and methods for evaluating anti-inflammatory agents or drugs in subjects with asthma and/or an analogous disease associated with high oxidative and nitrative stress at the disease site. In certain embodiments, the methods comprise a step of assaying for decreased levels of superoxide dismutase activity in the blood, serum, or plasma of the subject. In certain embodiments, the methods comprise a step of assaying for elevated levels of one or more oxidatively-modified SOD isoforms or species in the blood, serum or plasma of the subject. Also provided are diagnostic kits for use in the present invention. In certain embodiments, such kits comprise at least one binding reagent that specifically binds to at least one oxidatively-modified SOD species.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE CLEVELAND CLINIC FOUNDATIONCLEVELAND OH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Comhair, Suzy Concord Township, US 4 10
Hazen, Stanley L Pepper Pike, US 68 227

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation